Epithelial cell adhesion molecule-targeted catumaxomab (NCT00132522, phase I of EMD 273066 for non-small-cell lung cancer) uses a bispecific antibody, which can combine epithelial cell adhesion molecules on tumour cells to enhance epithelial-specific delivery
VSMCs were isolated from the dissected aorta using enzymatic dissociation solution [HEPES dissolved in HBSS (15 mM, pH: 7.2-7.3), BSA (2 mg/ml), CaCl2 (0.2 mM), Soybean Trypsin Inhibitor (0.25 mg/ml), elastase (0.0625 mg/ml) and collagenase (0.5 mg/ml)] (39)
This article describes the discovery and preclinical characterization of the first long-acting GLP1R GIPR co-agonist
This facewashs gentleness allows for easy absorption
Here are the key benefits
All use must comply with applicable laws, regulations, and laboratory safety standards.